Sofinnova Investments’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
IWA
Sofinnova Investments's PDSB Position: Q3 2024 in Review
Sofinnova Investments sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 142,635 shares — an estimated $418K sold.
Sofinnova Investments first reported a position in PDSB in Q1 2018 and held it in 26 quarters. The position peaked at $3.37M in Q1 2018. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.
- Sofinnova Investments reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
- Sofinnova Investments sold 142,635 PDS Biotechnology shares in Q3 2024, an estimated $418K.
- Sofinnova Investments first reported a position in PDS Biotechnology in Q1 2018 and held it in 26 quarters.
- Sofinnova Investments's PDS Biotechnology position peaked at $3.37M in Q1 2018.
- 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.
Based on Sofinnova Investments's 13F filing for Q3 2024, filed 13 Nov 2024.